Loading Events
uicc event image

Virtual Dialogue: Cancer patients are the most obvious victims of the superbug crisis

16th November 2023 @ 2:00 pm - 4:00 pm GMT

Register Here

Virtual Dialogue: Cancer patients are the most obvious victims of the superbug crisis

Thu 16th November @ 2:00 pm – 4:00 pm  GMT 
Hosted by: Union for International Cancer Control (UICC)

Antimicrobial resistance (AMR) is a public health issue that needs urgent attention at the global, national and health facility levels. Infections become drug-resistant when the pathogens that cause them adapt and change over time, developing the ability to resist the medicines designed to kill them. The result is that many antimicrobial medicines – like antibiotics and antifungals – are becoming less effective at treating illnesses. Our overuse of antibiotics in both humans and animals is speeding up this process. Many antimicrobials like antibiotics and antifungals are vital for routine surgery and lifesaving treatments like chemotherapy and radiotherapy.

People with cancer are more susceptible to infections due to the lowering of their immune defences. As many as one in five cancer patients undergoing treatment is hospitalized due to an infection and infections are the second leading cause of death for people living with cancer. 1 The emergence of drug-resistant pathogens are seriously affecting cancer care outcomes and if we don’t act now, all the progress made in cancer care will be undermined.

In this regard, addressing AMR for better cancer care outcomes is a priority for UICC and the UICC led AMR and cancer care Task Force. The focus areas identified by the task force include the (i) importance of data and surveillance systems, (ii) ensuring access to treatment including R&D for innovative treatments and good infection prevention and control practises and (iii) multistakeholder collaboration between the cancer and infectious diseases communities. This UICC virtual dialogue will focus on these areas.
The first High Level Meeting on AMR took place at the UN General Assembly in 2016 and the next one will take place next year. There is an urgent need for key players to come together in keeping the momentum on innovative ways to address AMR, increase collaborative networks and ensure there is commitment from all the relevant actors. The meeting next year must result in clear and measurable action with adequate funding and concrete next steps.

In this regard, the London Global Cancer week is an annual event that brings together all the relevant stakeholders and experts in the field. It is an ideal platform to bring together experts from the cancer and AMR fields to discuss what action needs to be taken to address this challenge.

Objective and expected results
The expected results from this session include:
– Focus on the need for stronger systems of surveillance (including data sharing)
– Focus on the issue of sustainable access to and rational use of antibiotics and diagnostics to address AMR, and ensuring its high on the global oncology agenda.
– Consensus on strengthening collaboration towards finding novel solutions and in its
implementation at the global, national and health facility levels.

For more information, including agenda and speaker line up, please click here

Share This Event

  • This event has passed.

Details

  • Date: 16th November 2023
  • Time:
    2:00 pm - 4:00 pm GMT